Remedy to Diabetes Distress (R2D2): Development protocol for a scalable screen-to-treat program for families of school-age children.
Remedy to Diabetes Distress (R2D2): Development protocol for a scalable screen-to-treat program for families of school-age children.
复制标题
DOI：
10.1016/j.cct.2022.106829
复制
发表时间：
2022-08
影响因子：
2.2
通讯作者：
Clements, Mark A.
中科院分区：
文献类型：
--
作者：
Patton, Susana R.;Pierce, Jessica S.;Fox, Larry;Benson, Matthew;Mc Donough, Ryan;Clements, Mark A.
学龄儿童1型糖尿病（T1 D）需要父母或其他成人照顾者（照顾者）的帮助，以有效地管理T1 D，导致儿童和照顾者更容易受到糖尿病困扰（DD）的影响。不幸的是，没有可扩展的筛查治疗计划可供诊所采用，以识别和治疗学龄家庭中的DD。我们的目标是为学龄儿童家庭设计一个可扩展的、基于临床的DD筛查治疗计划，并测试我们减少护理人员和儿童DD的新计划是否也能降低儿童血糖水平。我们的糖尿病痛苦补救（R2D2）计划将针对护理人员和8-12岁的T1 D儿童。它将在临床环境中对DD进行常规和自动化监测，并在家中提供基于理论的DD行为和心理治疗。我们将使用ORBIT行为干预开发模型来指导四项小型且具有成本效益的形成性研究，以开发我们的R2D2计划并评估初始治疗效果。与此同时，我们将在学龄家庭中实施以诊所为基础的DD筛查，并评估我们的筛查平台作为质量改进活动的可行性和可接受性。该研究于2020年9月开始，计划于2025年结束。本研究将使用一个机构审查委员会（IRB），Children's Mercy-Kansas City作为记录IRB。我们将通过在科学会议上的演讲以及通过心理学和糖尿病护理社区阅读的同行评审期刊来传播研究结果。
School-age children with type 1 diabetes (T1D) need help from parents or other adult caregivers (caregivers) to effectively manage T1D, resulting in greater vulnerability to Diabetes Distress (DD) for both children and caregivers. Unfortunately, there are no scalable screen-to-treat programs for clinics to adopt to identify and treat DD in school-age families. We aim to design a scalable, clinic-based screen-to-treat program for DD in families of school-age children and to test whether our new program to reduce caregiver and child DD also reduces child glycemic levels. Our Remedy to Diabetes Distress (R2D2) program will target caregivers and children with T1D who are between 8-12 years old. It will merge routine and automated surveillance of DD in the clinical setting with at home digital delivery of a theory-based behavioral and psychological treatment of DD. We will use the ORBIT Model for Behavioral Intervention development to guide four small and cost-effective formative studies to develop our R2D2 program and assess initial treatment effects. In tandem, we will implement clinic-based DD screening in school-age families and assess feasibility and acceptability of our screening platform as a Quality Improvement activity. The study started in September 2020 and is scheduled to conclude in 2025. The study will use a single Institutional Review Board (IRB) with Children’s Mercy-Kansas City operating as the IRB of record. We will disseminate study results through presentations at scientific conferences and through peer-reviewed journals read by the psychology and diabetes care communities.
登录
查看更多内容
影响因子：
4.2
作者：
Czajkowski, Susan M.;Powell, Lynda H.;Charlson, Mary E.
通讯作者：
Charlson, Mary E.
影响因子：
16.2
作者：
通讯作者：
--
影响因子：
3.6
作者：
Pierce, Jessica S.;Aroian, Karen;Wysocki, Tim
通讯作者：
Wysocki, Tim
影响因子：
4
作者：
Gale NK;Heath G;Cameron E;Rashid S;Redwood S
通讯作者：
Redwood S
影响因子：
3.5
作者：
Fisher, Lawrence;Hessler, Danielle;Masharani, Umesh
通讯作者：
Masharani, Umesh